Skip to Main Content

Paper Details

Complications, revision fusions, readmissions, and utilization over a 1-year period after bone morphogenetic protein use during primary cervical spine fusions.
Spine J
17
2014
Author NameAffiliation
Timothy S CareyCecil G. Sheps Center for Health Services Research, University of North Carolina at Chapel Hill
  • 1 - 1

Datasets

Release 1.2